| Serial Number | 88073859 |
| Word Mark | AB CHECK |
| Filing Date | Friday, August 10, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 8, 2023 |
| Registration Number | 7133412 |
| Registration Date | Tuesday, August 8, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 29, 2020 |
| Description of Mark | The mark consists of letters "AB" and "CHECK" separated by an array of circles. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "AB" OR "CHECK" |
| Goods and Services | Scientific and technological services and research projects for the preparation of peptide and antibody libraries, namely, chemical analysis; scientific and technological services and research projects for the identification and characterisation of binding molecules, namely, in the field of antibody discovery, antibody research and antibody optimization in the nature of working on and evaluation of chemical analyses; scientific and technological services and research projects for the preparation, identification and characterisation of peptides and antibodies, namely, medical research in the field of antibody discovery, antibody research and antibody optimization; scientific and technological services and research projects for the preparation and identification of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, and antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely, in the field of antibody discovery, antibody research and antibody optimization, namely, scientific research in the field of antibodies; scientific and technological services and research projects in relation to antibody discovery, namely, medical research in the field of antibody research and drug design; scientific and technological services and research projects in relation to screening of natural, engineered and immunized libraries, namely, medical research in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to screening of antibody libraries, namely, in the field of antibody discovery for scientific research services; scientific and technological services and research projects in relation to phage display, phage panning and yeast display vectors, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to next-generation yeast display and antibody selection process, namely, in the field of antibody discovery in the nature of chemical analysis; scientific and technological services and research projects in relation to the upstream enrichment of target-specific candidates and batch cloning into yeast-display vectors in the nature of research and development services in the field of antibodies; scientific and technological services in relation to drug discovery by high throughput screen and antibody delivery for therapeutic application, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely, scientific research in the field of antibodies and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely, in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely, scientific research in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely, scientific research in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and non-human lead antibody technology, namely, scientific research in the field of antibody research and antibody optimization |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, August 18, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, September 27, 2021 |
| First Use In Commerce Date | Monday, September 27, 2021 |
| Party Name | AbCheck s.r.o. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Plzen 30100 CZ |
| Party Name | AbCheck s.r.o. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Plzen 30100 CZ |
| Party Name | AbCheck s.r.o. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Plzen 30100 CZ |
| Event Date | Event Description |
| Tuesday, August 8, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 8, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 6, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, July 5, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Friday, June 9, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 8, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, June 8, 2023 | SOU EXTENSION 5 GRANTED |
| Wednesday, May 24, 2023 | SOU EXTENSION 5 FILED |
| Wednesday, May 24, 2023 | USE AMENDMENT FILED |
| Tuesday, May 30, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 24, 2023 | TEAS EXTENSION RECEIVED |
| Wednesday, May 24, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, November 1, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 28, 2022 | SOU EXTENSION 4 GRANTED |
| Friday, October 28, 2022 | SOU EXTENSION 4 FILED |
| Friday, October 28, 2022 | TEAS EXTENSION RECEIVED |
| Thursday, May 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 17, 2022 | SOU EXTENSION 3 GRANTED |
| Tuesday, May 17, 2022 | SOU EXTENSION 3 FILED |
| Tuesday, May 17, 2022 | TEAS EXTENSION RECEIVED |
| Thursday, October 28, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 26, 2021 | SOU EXTENSION 2 GRANTED |
| Tuesday, October 26, 2021 | SOU EXTENSION 2 FILED |
| Tuesday, October 26, 2021 | TEAS EXTENSION RECEIVED |
| Thursday, April 22, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 20, 2021 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 20, 2021 | SOU EXTENSION 1 FILED |
| Tuesday, April 20, 2021 | TEAS EXTENSION RECEIVED |
| Tuesday, November 24, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 29, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 29, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 9, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 26, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 25, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 25, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Sunday, April 19, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, April 19, 2020 | FINAL REFUSAL E-MAILED |
| Sunday, April 19, 2020 | FINAL REFUSAL WRITTEN |
| Thursday, January 16, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 15, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 15, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 17, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 17, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 17, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, June 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 13, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 2, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 2, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 2, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 28, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, August 21, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, August 18, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 14, 2018 | NEW APPLICATION ENTERED |